Showing results (71-80 of 182) with videos related to

Sort By:
Pageof 19
The Journal of Antimicrobial Chemotherapy|April 20, 2011
Evolutionary pathways of transmitted drug-resistant HIV-1Marieke Pingen, Monique Nijhuis, Johan A de Bruijn, et al.
Hepatology (Baltimore, Md.)|September 11, 2010
Prediction of sustained response to peginterferon alfa-2b for hepatitis B e antigen-positive chronic hepatitis B using on-treatment hepatitis B surface antigen declineMilan J Sonneveld, Vincent Rijckborst, Charles A B Boucher, et al.
Arteriosclerosis, Thrombosis, and Vascular Biology|January 15, 1999
Cellular cholesterol transport and efflux in fibroblasts are abnormal in subjects with familial HDL deficiencyM Marcil, L Yu, L Krimbou, et al.
Drugs|March 29, 2003
Therapeutic drug monitoring: an aid to optimising response to antiretroviral drugs?Rob E Aarnoutse, Jonathan M Schapiro, Charles A B Boucher, et al.
AIDS (London, England)|December 31, 2008
HIV monotherapy with ritonavir-boosted protease inhibitors: a systematic reviewWouter F W Bierman, Michiel A van Agtmael, Monique Nijhuis, et al.
Atherosclerosis|September 16, 1999
Familial hypercholesterolemia. Acceptor splice site (G-->C) mutation in intron 7 of the LDL-R gene: alternate RNA editing causes exon 8 skipping or a premature stop codon in exon 8. LDL-R(Honduras-1) [LDL-R1061(-1) G-->C]L Yu, E Heere-Ress, B Boucher, et al.
Presse Medicale (Paris, France : 1983)|March 7, 2002
[Silent myocardial ischemia in type 2 diabetes. Predictive value of intima-media thickness]B Boucher, A Cerisier, K Bouchou, et al.
Journal of Medical Virology|January 20, 2009
Occult hepatitis B in persons infected with HIV is associated with low CD4 counts and resolves during antiretroviral therapyJames W T Cohen Stuart, Marieke Velema, Rob Schuurman, et al.
The Journal of Infectious Diseases|July 12, 2011
Serum HBsAg decline during long-term potent nucleos(t)ide analogue therapy for chronic hepatitis B and prediction of HBsAg lossRoeland Zoutendijk, Bettina E Hansen, Anneke J van Vuuren, et al.
Nederlands Tijdschrift Voor Geneeskunde|December 14, 2004
[Patients co-infected with HIV and hepatitis-B virus (HBV): the favourable effect of lamivudine, as part of combined antiretroviral therapy, on HBV may be dependent upon the number of CD4-cells]M C A Smit, M H Haverkamp, A J L Weersink, et al.
Pageof 19